Dr. Philip M Arlen to present Keynote at the 6th Ace Drug Discovery Summit, London, UK, February 19, 2026

Precision Biologics, Inc. CEO Philip M Arlen, MD will give a Keynote speech and present “PB-223, A Novel Antibody Drug Conjugate Targeting Truncated Core-2 glycans in Solid Tumors”, at the 6th Ace Drug Discovery Summit, The Insurance Hall, London, UK, February 18-19, 2026.

February 19, 12:00pm – 12:30pm – Presentation no. 15

“PB-223, A Novel Antibody Drug Conjugate Targeting Truncated Core-2 glycans in Solid Tumors”

Keynote Speaker: Philip Arlen, President & CEO, Precision Biologics, Inc.